Promidian, an EVERSANA™ Company
Kevin has served as a strategic advisor to leading life-science companies for 2 decades. His consulting expertise spans a broad range of arenas, including corporate strategy, portfolio and product strategy, pricing and market-access strategy, and operational effectiveness.
Kevin has authored numerous articles and presented at myriad industry conferences on key strategic issues facing the pharmaceutical and biotechnology industries.
He has been quoted and referenced in leading business publications and industry trade journals, including Bloomberg Businessweek, Pink Sheet, The RPM Report, Pharmaceutical Executive, Med Ad News, PharmaVOICE, and Managed Healthcare Executive.
Kevin holds an MBA from the Indiana University Kelley School of Business and a BS in bioengineering from Purdue University.